NCT00782197 - Autologous Plasma Rich in Growth Factors (PRGF) Treating the Symptomatic Knee OA | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

January 31, 2008

Conditions

Joint Disease

Interventions

DEVICE

PRGF Intraarticular injection

Three consecutive PRGF injections each one week apart.

DEVICE

Hyaluronic Acid Intraarticular injection

Three consecutive Hyaluronic acid (EUFLEXXA) injections, each one week apart.

Trial Locations (3)

UCA (Unidad de Cirugía Artroscopica Mikel Sanchez.) Clinica USP La Esperanza., Vitoria-Gasteiz

Hospital Donostia., Donostia / San Sebastian

Policlinica Gipuzkoa, Donostia / San Sebastian